Watson syndrome: is it a subtype of type 1 neurofibromatosis?
Judith Allanson(Addenbrooke's Hospital), Peter S. Harper(University Hospital of Wales), G. H. Watson(Children's Hospital of Eastern Ontario), M. W. Partington(University of King's College), Meena Upadhyaya(Cardiff University), W Broadhead(Children's Hospital of Eastern Ontario), M. Sarfarazi(UConn Health), D Lahey(Children's Hospital of Eastern Ontario), H. H. B. Macleod(Children's Hospital of Eastern Ontario), Alexander MacKenzie(Children's Hospital of Eastern Ontario)
Cited by 108
Related Papers
Further segregation analysis of the fragile X syndrome with special reference to transmitting males
|Human Genetics|1985|512
PAK3 mutation in nonsyndromic X-linked mental retardation
|Nature Genetics|1998|472
Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy
|Nature Genetics|2002|437
The NF1 somatic mutational landscape in sporadic human cancers
|Human Genomics|2017|301
Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation
|The American Journal of Human Genetics|2008|223